STK-1

Soon after the COVID-19 outbreak, a SARS-CoV-2 variant bearing D614G mutation in S outside of the RBD emerged and quickly became the dominant strain in circulation6,7

  • by

Soon after the COVID-19 outbreak, a SARS-CoV-2 variant bearing D614G mutation in S outside of the RBD emerged and quickly became the dominant strain in… Read More »Soon after the COVID-19 outbreak, a SARS-CoV-2 variant bearing D614G mutation in S outside of the RBD emerged and quickly became the dominant strain in circulation6,7

Across multiple preclinical choices, synergistic effects have been reported using antiendoglin and anti\VEGF agents to simultaneously block both pathways [29]

  • by

Across multiple preclinical choices, synergistic effects have been reported using antiendoglin and anti\VEGF agents to simultaneously block both pathways [29]. In Mouse monoclonal to CD3/HLA-DR… Read More »Across multiple preclinical choices, synergistic effects have been reported using antiendoglin and anti\VEGF agents to simultaneously block both pathways [29]